Cargando…

Long-term prognosis and management of hepatocellular carcinoma after curative treatment

Detalles Bibliográficos
Autor principal:	Nishida, Naoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641545/ https://www.ncbi.nlm.nih.gov/pubmed/32951413 http://dx.doi.org/10.3350/cmh.2020.0208

Ejemplares similares

Metabolic disease as a risk of hepatocellular carcinoma
por: Nishida, Naoshi
Publicado: (2021)

The prognosis of hepatocellular carcinoma after curative hepatectomy in young patients
por: Ha, Sang Yun, et al.
Publicado: (2015)

Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2023)

Radiofrequency Ablation Combined with Resection Enhances Chance for Curative Treatment of Hepatocellular Carcinoma
por: Poon, Ronnie T. P.
Publicado: (2007)

Network meta-analysis of the prognosis of curative treatment strategies for recurrent hepatocellular carcinoma after hepatectomy
por: Chen, Jen-Lung, et al.
Publicado: (2023)

Operation start time and long-term outcome of hepatocellular carcinoma after curative hepatic resection
por: Lu, Qiang, et al.
Publicado: (2020)

Long-term outcome and prognostic factors of combined hepatocellular carcinoma and cholangiocarcinoma after curative resection
por: Jiang, Xing-Xing, et al.
Publicado: (2020)

Long-term prognosis after resection of cryptogenic hepatocellular carcinoma
por: Ohkura, Yu, et al.
Publicado: (2015)

Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters
por: Hao, Ke, et al.
Publicado: (2009)

Impact of Diabetes Mellitus on the Prognosis of Patients with Hepatocellular Carcinoma after Curative Hepatectomy
por: Wang, Yan-Yan, et al.
Publicado: (2014)

Immune Phenotype and Immune Checkpoint Inhibitors for the Treatment of Human Hepatocellular Carcinoma
por: Nishida, Naoshi, et al.
Publicado: (2020)

Impact of comorbid renal dysfunction in patients with hepatocellular carcinoma on long-term outcomes after curative resection
por: Sakamoto, Yuzuru, et al.
Publicado: (2022)

Prognosis after intrahepatic recurrence in the patients who underwent curative resection for hepatocellular carcinoma
por: Lee, Juhyeon, et al.
Publicado: (2020)

Systemic Hepatic-Damage Index for Predicting the Prognosis of Hepatocellular Carcinoma after Curative Resection
por: Gao, Xing-hui, et al.
Publicado: (2017)

Long-term oncological prognosis after curative-intent liver resection for hepatocellular carcinoma in the young versus the elderly: multicentre propensity score-matching study
por: Pu, Jia-Le, et al.
Publicado: (2022)

How long should physicians follow up with patients after curative treatment for hepatocellular carcinoma?
por: Kim, Bo Hyun
Publicado: (2020)

An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma
por: Kanda, Mitsuro, et al.
Publicado: (2017)

Advances in Immunotherapy for Hepatocellular Carcinoma
por: Hagiwara, Satoru, et al.
Publicado: (2023)

Management of sub-centimeter recurrent hepatocellular carcinoma after curative treatment: Current status and future
por: Lee, Min Woo, et al.
Publicado: (2018)

High RPS11 level in hepatocellular carcinoma associates with poor prognosis after curative resection
por: Zhou, Chenhao, et al.
Publicado: (2020)

Inflammation-nutrition scope predicts prognosis of early-stage hepatocellular carcinoma after curative resection
por: Zhu, Ying, et al.
Publicado: (2017)

Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods
por: Kuo, Ming-Jeng, et al.
Publicado: (2021)

Advanced nonmetastatic hepatocellular carcinoma: curative surgery may be an option
por: Leclerc, Julie, et al.
Publicado: (2022)

Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma
por: Ren, Zhigang, et al.
Publicado: (2020)

Long-term Survival of Patients with Cholangiolocellular Carcinoma After Curative Hepatectomy
por: Ariizumi, Shun-ichi, et al.
Publicado: (2014)

Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade
por: Toyoda, Hidenori, et al.
Publicado: (2016)

Role of Oncogenic Pathways on the Cancer Immunosuppressive Microenvironment and Its Clinical Implications in Hepatocellular Carcinoma
por: Nishida, Naoshi
Publicado: (2021)

The Optimal Management for Sub-Centimeter Hepatocellular Carcinoma: Curative Treatments or Follow-Up?
por: Sun, Xuqi, et al.
Publicado: (2019)

Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection
por: Kuang, Xuejun, et al.
Publicado: (2018)

The association between KLF4 as a tumor suppressor and the prognosis of hepatocellular carcinoma after curative resection
por: Xue, Min, et al.
Publicado: (2020)

Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection
por: Meng, Jun, et al.
Publicado: (2019)

Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma
por: Okabe, Hirohisa, et al.
Publicado: (2018)

High GCLC level in tumor tissues is associated with poor prognosis of hepatocellular carcinoma after curative resection
por: Sun, Jialei, et al.
Publicado: (2019)

Genetic and Epigenetic Signatures in Human Hepatocellular Carcinoma: A Systematic Review
por: Nishida, Naoshi, et al.
Publicado: (2011)

Risk factors for long-term prognosis of hepatocellular carcinoma patients after anatomic hepatectomy
por: Tian, Ya-Li, et al.
Publicado: (2020)

Effects of Serum Lipids on the Long-Term Prognosis of Ampullary Adenocarcinoma Patients after Curative Pancreatoduodenectomy
por: Li, Zheng, et al.
Publicado: (2022)

Long-term outcomes and prognosis for patients with sarcomatoid hepatocellular carcinoma
por: Zhou, Cheng, et al.
Publicado: (2022)

Considerations of systemic treatment for matrix-producing carcinoma with curative intent
por: de Paula, Bruno, et al.
Publicado: (2022)

Adjuvant therapies after curative treatments for hepatocellular carcinoma: Current status and prospects
por: Zhu, Xiao-Dong, et al.
Publicado: (2020)

Long-Term Survival in Patients With T2 Hepatocellular Carcinoma After Primary Curative Resection Can Be Further Stratified by Tumor Size
por: Ho, Cheng-Maw, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_aa54sd87cnd0f3jauerlvbf7qh